8VC is a Silicon-Valley based technology investment firm investing in visionary teams and backing industry-transforming companies, currently managing $3.5bn in AUM. About one third of their current fund is dedicated towards the BioIT space. 8VC’s portfolio represents a large early crop of now next gen biotech unicorns including but not limited to Orca Bio, Synthego, Resilience, and Lyell Immunopharma which have generated playbooks for others startups to follow.Francisco Giminez and David Moskowitz are two integral members of the 8VC team which developed the Bio-IT investment thesis. Francisco is a Partner @ 8VC focusing on Bio-IT investments and Enterprise AI. He received a PhD from Stanford in Biomedical Informatics. During this time, he also worked as a Resident Data Scientist at Formation8 Partners where he helped startups to strategize, prototype, and recruit for data products. He also is the founder of Catenus Science, a data science consulting and recruiting firm that used an apprenticeship model to help early stage companies build data science teams. David is a Principal @ 8VC who also received his PhD at Stanford as part of the Biomedical Informatics Program. At Stanford, his work was focused on applying statistical and machine learning approaches to regulatory genomics, epigenetics, and pipeline development for analysis of high throughput sequencing data. Prior to his time at Stanford, David was a Bioinformatic Analyst at Einstein College of Medicine where he worked on the genetics of aging and human disease. Thank you for listening!BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.Music: Danger Storm by Kevin MacLeod (link & license)